A new definition and refocus of pharmaceutical care: the Barbate Document

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Morillo-Verdugo R
  • Calleja-Hernández MÁ
  • Robustillo-Cortes, MD

Grupos

Abstract

Objective: To propose an updated definition of Pharmaceutical Care based on the Capacity-Motivation-Opportunity (CMO) model and on the key elements and optimal activities for its development that guarantee the highest levels of quality and excellence in this professional activity. Method: The consensus was developed by a working group composed of members of the Spanish Society of Hospital Pharmacy and other pharmacists from different healthcare fields. A literature review of PubMed was conducted of the available scientific evidence on pharmaceutical healthcare models and activities with the greatest impact and ease of implementation. A working definition was developed and the initiatives chosen as key elements were collected and included in each pillar of the proposed model. After creating an initial list of activities and terms, the working group reviewed it and made corrections or proposed new activities. In addition, the definitions of the three key elements of the CMO model were agreed upon: Capacity-Motivation-Opportunity. In order to incorporate all appropriate suggestions and contributions before finalizing the consensus, the final draft was sent to the different scientific, pharmaceutical, and medical societies as well as patient associations with which the Spanish Society of Hospital Pharmacy has a collaboration agreement. Results: The definition of consensual Pharmaceutical Care was "Any professional activity by which the pharmacist is linked to the patient (and/or caregiver) and other healthcare professionals, to attend to the patient according to their needs, setting out strategies to align and achieve the short-and medium-/long-term objectives of pharmacotherapy and incorporating new technologies and the means available to continuously interact with the patients in order to improve their health outcomes". In addition, agreement was reached on the definitions of the three key elements of the CMO model. Finally, 27 key elements for the development of pharmaceutical activity were identified and included in the three pillars of the model. Conclusions: A new definition of Pharmaceutical Care has been agreed upon that refocuses this professional activity, allowing us to advance within the multidisciplinary working approach toward a longitudinal and multidimensional approach to the patient.

Datos de la publicación

ISSN/ISSNe:
1130-6343, 2171-8695

FARMACIA HOSPITALARIA  ELSEVIER SCIENCE INC

Tipo:
Article
Páginas:
158-162
PubMed:
32646347
Enlace a otro recurso:
www.scopus.com
Factor de Impacto:
0,238 SCImago ℠
Cuartil:
Q4 SCImago ℠

Citas Recibidas en Web of Science: 26

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • Pharmaceutical Care; Pharmacy; Patient Outcomes Assessment; Healthcare Delivery; Clinical Pharmacy Service; Pharmacist; Hospital Pharmacy Service

Cita

Compartir